As new concepts for drug discovery evolve, synthetic organic chemistry is vital to the timely success of these programs. Adesis specializes in contractual syntheses and process optimization of milligrams to kilogram quantities including: Early stage proof-of-concept (POP) projects to validate biological hypotheses, Validation of screening hits for exploratory medicinal chemistry (hit-to-lead), Structure-activity relationship (SAR) optimization, Intermediates for expediting med chemistry SAR campaigns, Drug candidates for in vivo studies, Reference agents for bioprofiling, Reference metabolites, Proprietary scaffolds, Intermediates for pharmaceuticals, Intermediates for biomaterials and biosensors.
